Antibiotice S.A. (BVB:ATB)

Market Cap	1.67B
Revenue (ttm)	669.82M
Net Income (ttm)	87.13M
Shares Out	671.34M
EPS (ttm)	0.13
PE Ratio	19.14
Forward PE	n/a
Dividend	0.02 (0.83%)
Ex-Dividend Date	Sep 25, 2025

Volume	182,948
Average Volume	112,998
Open	2.510
Previous Close	2.480
Day's Range	2.470 - 2.510
52-Week Range	1.750 - 3.320
Beta	0.21
RSI	46.61
Earnings Date	Nov 20, 2025

About Antibiotice

Antibiotice S.A. produces and sells medicinal products in Romania and internationally. The company offers generic prescription medicines comprising anti-infectives, including drugs for the treatment of tuberculosis, as well as cardiovascular drugs, digestive tract and metabolism class, preparations for the treatment of gynecological diseases, and dermatological and central nervous system preparations; generic non-prescription medicines, including food supplements, cosmetics, and medical devices; active substances; biofertilizers; biocides for d...

• Industry: Pharmaceutical Preparations
• Founded: 1955
• Employees: 1,357
• Stock Exchange: Bucharest Stock Exchange
• Ticker Symbol: ATB

Financial Performance

In 2024, Antibiotice's revenue was 688.70 million, an increase of 11.93% compared to the previous year's 615.29 million. Earnings were 102.20 million, an increase of 26.04%.